At the close of business on 10 May 2022, Morten Opstad, Chair of the Board of
IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose
of the Annual General Meeting on 12 May 2022:
Total 339,456,666 shares or 33,53% of the share capital and votes, consisting of
the following:
* Proxy to represent and vote for 219,095,246 shares or 21,64% of the share
capital, including shares held by Mr Opstad and close relations
* Proxy with voting instructions for 120,361,420 shares or 11,89% of the share
capital.
For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=oK5zwNtRsZ1s5umKWlj0gvhxK4PRPMGHg8q9
WpY79SVXH4zYq--0sgcQP_Odo0-K69jgeZX2OpVVepCuqIf4kSf6qGBkxSGU_Vjk3s4scM-PtiXZkVss
8JPP0gq8wLKP)
Tel: + 47 918 00186
Brett L Perry, U.S. Investor Relations
E-mail: bperry@sheltongroup.com (mailto:bperry@sheltongroup.com)
Tel: + 1 214 272 0070
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDXBA) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
touch-free authentication for all. We help people make payments, prove their
identity, gain access to information, unlock devices or gain admittance to
buildings. We invent, engineer, and commercialize these secure and safe yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act